Koji Sasaki

Koji Sasaki is a Professor at The University of Texas MD Anderson Cancer Center, specializing in hematology and oncology. His research focuses on the clinical management of hematological malignancies, particularly chronic myeloid leukemia, acute myeloid leukemia, and Philadelphia chromosome-positive acute lymphoblastic leukemia. His recent work includes optimizing venetoclax-based triplet regimens with hypomethylating agents and isocitrate dehydrogenase inhibitors for AML, evaluating reduced venetoclax exposure schedules, and developing the BLAST survival model for chronic myelomonocytic leukemia. He has also investigated post-immunotherapy lineage switch relapse and treatment-free remission strategies. His contributions span pharmacology, pathology, and immunology, with publications in Blood, Cancer, and the Journal of Clinical Oncology.